How to choose hematology reagents compatible with your analyzer in a clinical laboratory

How to Choose the Right Hematology Reagents for Your Analyzer

Direct answer: The right hematology reagent should be compatible with your specific analyzer, meet required quality and regulatory standards, have reliable performance data, and fit your lab’s storage, usage and budget requirements. Before switching suppliers, verify analyzer compatibility, review validation and lot data, assess total cost of ownership, and run an in-house comparison to confirm consistent results.

TL;DR - Key Takeaways

  • How to choose hematology reagents correctly depends on analyzer compatibility, reagent purity, shelf life, regulatory compliance, and cost-effectiveness.
  • Always verify hematology reagent compatibility with your specific analyzer model before procurement.
  • Third-party hematology reagents can reduce costs but must match OEM performance standards.
  • EDTA is the gold standard anticoagulant for complete blood count (CBC) testing.
  • The Rule of 3 helps validate RBC, hemoglobin, and hematocrit results.
  • Consistent quality control (QC) protocols protect result accuracy and patient safety.

Why the Right Reagent Choice Matters

Every blood test result that guides a clinical decision - whether it’s diagnosing anaemia, detecting leukaemia, or monitoring a patient on chemotherapy - depends on the quality of the reagents behind the analysis. Laboratories that get this wrong can see result drift, instrument damage, warranty voiding, and - most critically - patient harm. For this reason, how to choose hematology reagents is a question that every lab manager and procurement officer should answer with care, evidence, and a structured process.

Knowing how to choose hematology reagents is therefore not just a procurement question. It is a clinical quality question. Labs across India and globally are increasingly realising that the brand on the box matters far less than the compatibility, purity, and consistency of what’s inside it.

According to data published by the UK National External Quality Assessment Service (NEQAS), reagent-related variables are among the most common sources of inter-laboratory discrepancy in haematology proficiency testing. Getting the selection process right the first time saves time, money, and risk.

What Are Hematology Reagents?

Direct answer: Hematology reagents are the chemical solutions an automated analyzer uses to dilute, lyse, stain and flush blood samples so that cells can be counted and classified accurately.

Hematology reagents are chemical solutions used in automated blood analyzers to process, stain, lyse, and count blood cells. They work in concert with the analyzer’s fluidics, optics, and electrical impedance systems to generate a complete blood count (CBC) and differential.

At their most fundamental level, these reagents fall into three functional groups:

  • Diluents - dilute the blood sample to a measurable concentration
  • Lysing agents (Lysers) - break open red blood cells to allow white blood cell differentiation and haemoglobin measurement
  • Cleansers/Rinse solutions - flush the system between samples to prevent carryover and maintain probe integrity

Each of these must interact precisely with both the blood sample and the analyzer’s internal mechanisms. That interaction is what makes hematology reagent compatibility so critically important - a topic we return to in detail below. Labs that want to see how these groups map onto specific 3-part and 5-part platforms can browse the hematology reagents range from Vanguard Diagnostics.

The Core Types of Hematology Reagents

Reagent TypeFunctionCommon Examples
DiluentSuspends cells for countingIsotonic saline-based solutions
Lyser/Lysing agentLyses RBCs, enables WBC differentialCyanide-free lysing reagents
Staining reagentDifferentiates cell types by optical propertiesPeroxidase, eosin-based dyes
CleanerRemoves debris and prevents blockagesEnzymatic or alkaline cleaners
Hematology controlsValidates analyzer performanceTri-level blood-like controls

Alongside reagents, hematology controls are equally important - they are the reference materials used to confirm that both the analyzer and the reagent system are performing within expected ranges.

How to Choose Hematology Reagents: 8 Factors That Matter

Direct answer: The eight factors are analyzer compatibility, reagent purity and grade, shelf life and storage, regulatory certification, performance validation data, technical support and supply reliability, environmental and safety profile, and total cost of ownership. Compatibility is always the first filter.

When labs ask how to choose hematology reagents, the answer is never a single criterion. It is a structured evaluation across multiple dimensions. Here are the eight factors that should guide every procurement decision.

1. Analyzer Compatibility

How to choose hematology reagents for a specific instrument is the first and most critical step any lab should take. This is the starting point. How to choose hematology reagents correctly begins with a thorough review of the analyzer’s technical manual. Every analyzer - whether it’s a Mindray, Sysmex, URIT, Rayto, or Nihon Kohden model - has specific reagent volume requirements, pressure tolerances, chemical specifications, and optical requirements.

Using a reagent not calibrated for your instrument risks:

  • Incorrect cell differentiation
  • Clogged probes from incompatible surfactant concentrations
  • Warranty invalidation from the instrument manufacturer
  • Systematic bias in CBC results

Hematology reagent compatibility is covered in more detail in the dedicated section below, but even at this stage, it must be the first filter applied.

2. Reagent Purity and Grade

Laboratory-grade reagents are manufactured under strict quality protocols that govern raw material sourcing, production environment, batch consistency, and finished product testing. When considering how to choose hematology reagents, look for:

  • ISO 13485 certified manufacturers
  • CE marking for IVD use (In Vitro Diagnostics)
  • Lot-to-lot consistency data
  • Coefficient of variation (CV) data - a CV below 5% is generally considered acceptable for hematology parameters

Poor reagent purity introduces background noise, artifactual cell populations, and result variability that is difficult to distinguish from true clinical findings.

3. Shelf Life and Storage Requirements

Reagents degrade over time, and improper storage accelerates that degradation. Always confirm:

  • Manufacturer-stated shelf life (unopened and in-use)
  • Required storage temperature range
  • Sensitivity to light or humidity
  • Stability after opening (many lysing agents have a 30-day in-use window once opened)

Ordering reagents in bulk may seem economical, but it is counterproductive if your lab cannot use them before expiry. A practical approach to how to choose hematology reagents includes aligning ordering volumes with actual consumption rates.

4. Regulatory and Certification Standards

In India, the Central Drugs Standard Control Organisation (CDSCO) regulates IVD reagents under the Medical Devices Rules, 2017. Internationally, key standards include:

  • CE-IVD (Europe)
  • FDA 510(k) clearance (United States)
  • ISO 15189 laboratory accreditation compliance

Reagents that carry appropriate regulatory approvals have been tested for safety, performance, and labelling accuracy. When thinking through how to choose hematology reagents, confirming regulatory compliance protects the lab legally and clinically.

5. Performance Validation Data

Any reagent supplier worth its reputation will be able to provide independent performance data. Request:

  • Precision studies (within-run and between-run CV)
  • Linearity data across the reportable range
  • Comparison studies against a reference method or OEM reagent
  • Interference studies (e.g., lipemia, icterus, haemolysis)

This data is the scientific backbone of how to choose hematology reagents for any testing environment that values accuracy over assumption.

6. Technical Support and Supply Reliability

Even the best reagent is only valuable when it arrives on time and when technical issues can be resolved quickly. Evaluate:

  • Supplier’s average delivery turnaround
  • Availability of technical support (field application specialists)
  • Backup supply agreements for high-volume labs
  • Track record of supply continuity during disruptions

Labs running high daily sample volumes cannot afford stockouts. Supply reliability is an underrated factor in how to choose hematology reagents that many labs overlook until it causes a crisis. A supplier that manufactures its own diagnostic reagents in India tends to have more control over lead times than one that only resells.

7. Environmental and Safety Profile

Modern labs increasingly operate under sustainability and occupational health mandates. Cyanide-containing lysing agents, for example, are being phased out in favour of cyanide-free alternatives that maintain equivalent performance. When thinking through how to choose hematology reagents in 2025 and beyond:

  • Prefer reagents with low hazard classifications
  • Check biohazard disposal requirements
  • Evaluate chemical safety data sheets (SDS) for staff exposure risks
  • Consider reagents with lower environmental impact

The Health and Safety Executive (UK) provides clear guidance on managing chemical and biological hazards in clinical laboratory environments - useful reading for any lab manager evaluating reagent safety profiles.

8. Cost-Effectiveness (Total Cost, Not Just Unit Price)

Price matters, but unit price is rarely the whole story. The total cost of ownership for a reagent includes:

  • Waste from expired product
  • Cost of repeat testing due to poor performance
  • Time spent troubleshooting compatibility issues
  • Any instrument repair costs linked to reagent damage

When applying a true cost-of-ownership lens to how to choose hematology reagents, a moderately priced reagent with excellent performance often outperforms a cheap one that generates reruns.

Hematology Reagent Compatibility: The Non-Negotiable Factor

Direct answer: A hematology reagent is compatible only if its viscosity, surfactant chemistry, osmolality and optical behaviour match what your analyzer model was designed to use. Brand name alone does not guarantee that, so confirm it with analyzer-specific data from the manufacturer.

Hematology reagent compatibility is the foundation on which all other selection criteria rest. Every time a lab revisits how to choose hematology reagents, this is the dimension that must come first. An incompatible reagent - even one of excellent purity and regulatory standing - will produce unreliable results when used with an analyzer it was not designed for.

Compatibility operates at several levels:

Fluidics Compatibility

The reagent’s viscosity, surfactant content, and osmolality must align with the analyzer’s pump pressures, tubing dimensions, and flow cell specifications. A diluent that is too viscous can slow sample transit and affect cell transit time through the aperture or laser.

Chemical Compatibility

The lyser’s detergent chemistry must interact correctly with the red cell membrane to achieve complete lysis without damaging white cell populations. If lysis is incomplete, the white cell differential will be skewed. If lysis is too aggressive, white cells may be damaged and misclassified.

Optical/Impedance Compatibility

For analyzers using light scatter (laser-based 5-part differential), reagents must produce the correct refractive index and cell shrinkage patterns to allow the instrument’s software to distinguish neutrophils from lymphocytes, monocytes from eosinophils, and so on. This is highly instrument-specific, which is why hematology reagent compatibility cannot be assumed across brands.

Practical Tip

Always request an application note or compatibility data sheet from the reagent manufacturer specific to your analyzer model. For labs running multiple analyzer types, maintain a compatibility matrix as a live document and review it at each reagent re-procurement cycle.

The hematology reagents range from Vanguard Diagnostics is developed for a range of leading analyzers - including Mindray, Sysmex, URIT, Rayto, Prokan, and Nihon Kohden models - with compatibility validated through formal performance studies. For 3-part platforms, the three families of labs ask about most; each has a matched set on Vanguard’s e-Mart:

On the 5-part side, Vanguard-branded reagents are supplied under licence from Diagon, Hungary, for Mindray BC-5000, 5150, 5300 and 5800 models and Sysmex XS-800i and XS-1000i models. Every other analyzer in the full e-Mart hematology reagent collection is listed by instrument, which makes it easier to match a pack to a model before ordering.

Not sure which reagent set fits your analyzer? Share your instrument model and monthly sample volume with the Vanguard Diagnostics team through the contact page, and they can confirm compatibility data and trial options for you.

Third-Party Hematology Reagents: Pros, Cons & What to Watch

Direct answer: Third-party hematology reagents are a credible way to cut running costs and avoid single-supplier lock-in, provided the manufacturer holds ISO 13485 and IVD approvals, and the lab completes an in-house validation against its current OEM reagent before switching.

One of the most common questions lab managers grapple with is whether to stay with OEM (original equipment manufacturer) reagents or switch to third-party hematology reagents. It is a genuinely complex decision with legitimate arguments on both sides.

The Case for Third-Party Hematology Reagents

Third-party hematology reagents - those produced by manufacturers independent of the analyzer OEM - have matured significantly in quality and have become a credible option for many labs. The primary advantages include:

  • Cost savings: Third-party reagents typically cost 20-50% less than OEM equivalents
  • Supply flexibility: Labs are not locked into a single supplier’s pricing or lead times
  • Cross-instrument adaptability: Some third-party manufacturers offer a single product line compatible with multiple instrument brands
  • Transparency: Independent manufacturers often provide detailed performance data not available in OEM literature

The Risks and Mitigation

That said, third-party hematology reagents carry real risks when not selected carefully:

  • Compatibility gaps: Without rigorous validation, subtle chemical differences can produce result drift
  • Warranty concerns: Some instrument manufacturers may void service warranties if third-party reagents are used - always check your service agreement
  • Regulatory grey areas: Regulatory approval for a reagent with a specific analyzer may not automatically transfer to third-party equivalents in all jurisdictions
  • Quality variability: The third-party market includes manufacturers at very different quality levels - ISO 13485 certification and IVD CE marking are minimum benchmarks

The decision of how to choose hematology reagents from third-party sources should always begin with a formal in-laboratory validation study comparing the candidate reagent to your current OEM reagent across a clinically representative sample set.

The Rule of 3 and the 5 Parameters of Hematology

What Is the Rule of 3 in Hematology?

The Rule of 3 is a quick internal validation check used in haematology to detect gross errors in CBC results. The rule states that when blood has a normal MCV (between approximately 80- 100 fL), the following relationship should hold:

  • Haemoglobin (g/dL) × 3 ≈ Haematocrit (%)
  • RBC (×10¹²/L) × 3 ≈ Haemoglobin (g/dL)

For example, if a patient’s RBC is 4.5 × 10¹²/L, their haemoglobin should be approximately 13.5 g/dL, and their haematocrit approximately 40.5%.

When these relationships fall out of expected alignment - especially in samples that have not been flagged for a clinical reason - the Rule of 3 signals a possible reagent issue, instrument error, or sample integrity problem. This is one reason why choosing haematology reagents matters beyond single-parameter accuracy: errors often manifest across the full CBC panel.

The 5 Parameters of Hematology

A standard 3-part differential hematology analyzer reports these five primary parameters:

  1. RBC (Red Blood Cell count)
  2. WBC (White Blood Cell count)
  3. Hemoglobin (Hgb)
  4. Hematocrit (HCT)
  5. Platelets (PLT)

From these, derived indices are calculated: MCV, MCH, MCHC, and RDW. A 5-part differential analyzer adds neutrophil, lymphocyte, monocyte, eosinophil, and basophil percentages and absolute counts.

Reagents must be calibrated to deliver accurate results across all of these parameters simultaneously. This is especially relevant when thinking through how to choose hematology reagents for 5-part differential platforms, where the lyser chemistry is considerably more complex.

Why EDTA Is the Anticoagulant of Choice in Haematology

EDTA (ethylenediaminetetraacetic acid) is the near-universal anticoagulant used for CBC and haematology testing. Its dominance is not arbitrary - EDTA’s chelation of calcium ions prevents clotting while preserving cell morphology better than other anticoagulants.

Key advantages of EDTA:

  • Cell preservation: Maintains red cell, white cell, and platelet morphology for up to 24 hours at room temperature
  • Platelet preservation: Unlike citrate, EDTA prevents platelet clumping that would give false thrombocytopaenia
  • Compatibility: EDTA is compatible with virtually all hematology analyzers and reagent systems

The standard concentration is 1.5-2.2 mg EDTA per mL of blood (in the EDTA-K2 or EDTA-K3 formulation). Overfilling or underfilling the collection tube changes this ratio and can affect results, particularly MCV and haematocrit.

Quality Control and Validation

Direct answer: Quality control confirms that a reagent performs correctly on your analyzer. Run tri-level hematology controls at the start of every shift and after every lot change, plot them on Levey-Jennings charts, and take part in an external quality assurance scheme.

Quality control (QC) is inseparable from reagent selection. The best reagent in the world is ineffective without a robust QC programme to confirm it is performing as expected on your specific instrument.

Levels of QC

Internal QC involves running hematology controls (tri-level, covering normal and abnormal ranges) at defined intervals - typically at the start of each shift and after any reagent lot change. Control results are plotted on Levey-Jennings charts and evaluated using Westgard rules.

External QC involves participating in external quality assurance (EQA) programmes such as NEQAS, where labs receive unknown samples, analyse them, and submit results for inter-laboratory comparison.

Both programmes are directly relevant to how to choose hematology reagents: a reagent that produces consistently in-control internal QC data and low bias in EQA schemes is demonstrably performing well.

Managing Reagent Lot Changes

Each new reagent lot - even from the same manufacturer - should be validated before introduction. Run the new lot in parallel with the current lot on at least 20 patient samples and compare results. Pay particular attention to parameters known to be reagent-sensitive, such as MCHC and WBC differential fractions.

The Vanguard Diagnostics quality framework, detailed on their quality page, describes the protocols applied to each reagent production batch - an example of the manufacturer-level quality transparency labs should expect.

Cost, Sustainability, and Regulatory Compliance

Balancing Cost and Quality

The pressure on lab budgets is real. How to choose hematology reagents within budget constraints is a legitimate operational challenge. A few practical approaches:

  • Consolidate suppliers: Reducing the number of reagent suppliers can enable volume discounts without sacrificing quality
  • Monitor consumption vs. expiry: Optimising order quantities to match consumption rates reduces waste
  • Evaluate total cost of ownership: Include QC failures, reruns, instrument downtime, and technical support calls in the cost comparison - not just the purchase price per litre.

Environmental Considerations

Labs are increasingly required to reduce their chemical waste footprint. Cyanide-free lysing reagents are now available for most analyzer platforms and offer comparable performance to legacy cyanide-based products. This is a practical dimension of how to choose hematology reagents that also responds to corporate sustainability targets.

Regulatory Compliance in India

Labs in India operating under NABL accreditation (ISO 15189) must use reagents with documented traceability and performance data. The use of unregistered or non-CDSCO-approved IVD reagents in accredited labs constitutes a compliance breach. This regulatory dimension is central to how to choose hematology reagents in the Indian diagnostic context.

Red Flags to Watch for When Selecting Reagents

When sourcing reagents - particularly third-party hematology reagents - several warning signs should prompt a closer look or an outright rejection:

  • No ISO 13485 certification or IVD regulatory approval
  • Inability to provide lot-specific QC certificates
  • Unusual pricing (significantly below market rate without explanation)
  • No published performance data or willingness to provide trial samples
  • Generic labelling without specific analyzer compatibility claims
  • History of supply disruptions or inconsistent delivery

A reagent that checks all the right boxes on paper but comes from a manufacturer unwilling to provide transparency should always be treated with caution. How to choose hematology reagents is ultimately a due diligence process - and due diligence means asking hard questions. Laboratories that consistently apply rigorous criteria when deciding how to choose hematology reagents are the ones that maintain the highest standards of diagnostic accuracy.

Ready to put a reagent set through your own validation? Vanguard Diagnostics can discuss trial quantities and lot data for your analyzer. Reach the team on the contact page, or browse the wider products and solutions range, which also covers biochemistry reagents and immunology tests for labs that want a single supplier.

Key Takeaways Summary

  • How to choose hematology reagents is a multi-dimensional decision combining compatibility, quality, regulatory compliance, cost, and supply reliability.
  • There is no shortcut to how to choose hematology reagents correctly - each factor in this guide represents a real-world risk that labs have experienced when they skipped it.
  • Hematology reagent compatibility with your specific analyzer model is the non-negotiable first criterion.
  • Third-party hematology reagents offer real cost benefits but require formal in-house validation before adoption.
  • The Rule of 3 is a simple internal check to identify reagent or instrument errors in CBC results.
  • EDTA-K2 is the gold-standard anticoagulant for haematology testing due to its superior cell preservation properties.
  • The 5 parameters - RBC, WBC, Hgb, HCT, and PLT - along with derived indices, all depend on reagent performance for accuracy.
  • Quality control at both internal and external levels is essential to confirm ongoing reagent performance.
  • Regulatory compliance (CDSCO in India, CE-IVD internationally) is a baseline requirement, not an optional extra.

You Might Also Wonder…

Can I mix reagents from different manufacturers on the same analyzer?

Generally, no - or at least, not without independent validation. Different reagent systems are optimised to work together. Mixing a diluent from Supplier A with a lyser from Supplier B may produce results that are neither reagent’s intended output, since the two chemistries were never designed to interact. Always use a validated, matched reagent system.

How often should I revalidate reagents?

At a minimum, on every new lot. Any significant change - new lot, new supplier, or instrument servicing - should trigger a mini-validation exercise. For high-volume labs, an annual comprehensive review of reagent performance data is good practice.

What role do hematology controls play alongside reagents?

Controls are the verification layer. They confirm that the reagent-instrument system is producing results within expected ranges. Without controls, you cannot distinguish a good reagent day from a bad one. The hematology controls from Vanguard Diagnostics are designed to work in tandem with their reagent systems for integrated quality assurance.

Looking for a reagent supplier that can match your analyzer? Talk to Vanguard Diagnostics about reagents and controls for your instrument, or order Mindray, Sysmex and Prokan packs directly from the Vanguard e-Mart.

Frequently Asked Questions

What is the Rule of 3 in hematology?

The Rule of 3 is a rapid internal validation check used in haematology laboratories to catch gross errors in CBC results. It states that in samples with a normal MCV, haemoglobin (in g/dL) multiplied by 3 should approximately equal the haematocrit (in %). Similarly, the RBC count (×10¹²/L) multiplied by 3 should equal the haemoglobin value. When these relationships fail to hold without a clinical explanation, it is a flag that reagent performance, instrument function, or sample integrity may be compromised.

What are the common reagents used in hematology testing?

The common reagents used in hematology testing are diluents, lysing agents, staining reagents, cleaners and rinse solutions, and hematology controls. Each plays a distinct role in producing an accurate CBC and differential. Diluents: Isotonic solutions that suspend blood cells at a concentration measurable by the instrument. Lysing agents: Detergent-based solutions that lyse red blood cells to free haemoglobin for measurement and to allow WBC counting and differentiation. Staining reagents: Used in optical-based systems to differentially stain cell populations for scatter-based identification. Cleaners and rinse solutions: Used to flush the analyzer's internal pathways between samples and prevent carryover. Hematology controls: Stabilised blood-based materials used to validate analyzer and reagent performance.

What are the most common tests used in hematology?

The most common hematology test is the complete blood count (CBC), which measures RBC, WBC, hemoglobin, hematocrit and platelets, along with derived indices such as MCV, MCH, MCHC and RDW. Other frequently ordered tests include: WBC differential: Counts neutrophils, lymphocytes, monocytes, eosinophils and basophils. Peripheral blood smear: A microscopic review of cell shape and size when the analyzer flags an abnormality. Reticulocyte count: Shows how actively the bone marrow is producing red cells. Erythrocyte sedimentation rate (ESR): A non-specific marker of inflammation. Coagulation tests: Prothrombin time (PT/INR) and activated partial thromboplastin time (aPTT), which assess clotting.

What are the 3 types of hematology?

The term is used in two ways. As a field, hematology is commonly divided into three broad areas: laboratory (clinical) hematology, which covers blood cell counts, morphology and anaemia or leukaemia work-ups; hemostasis and coagulation, which covers bleeding and clotting disorders; and transfusion medicine, which covers blood grouping, cross-matching and blood banking. In the lab itself, people also use the phrase for analyzer types, with 2-part, 3-part and 5-part differential analyzers separated by how many white cell populations they can distinguish. A 3-part analyzer separates lymphocytes, monocytes and granulocytes, while a 5-part analyzer reports neutrophils, lymphocytes, monocytes, eosinophils and basophils individually.

How to choose the best reagent?

Knowing how to choose hematology reagents that are truly the best fit for your lab comes down to these steps: confirm hematology reagent compatibility with your analyzer model; review the manufacturer's regulatory certifications (ISO 13485, CE-IVD); request and evaluate lot-specific performance data; assess shelf life relative to your consumption rate; evaluate total cost of ownership (not just unit price); confirm supply reliability; and perform an in-house validation study before switching. If considering third-party hematology reagents, run a comparative study against your current OEM reagent before adoption.

Why is EDTA used for haematology?

EDTA (ethylenediaminetetraacetic acid) is used as the anticoagulant for haematology blood samples because it chelates (binds) calcium ions, which are essential for the coagulation cascade. By removing free calcium, EDTA prevents clot formation without damaging blood cell morphology. It is particularly good at preserving platelet integrity - an important advantage since other anticoagulants like citrate can cause platelet clumping, which produces falsely low platelet counts. The standard EDTA collection tube contains 1.5-2.2 mg of EDTA per mL of blood, and maintaining the correct blood-to-EDTA ratio is essential for accurate CBC results.

What are the 5 parameters of hematology?

The five primary parameters measured by a standard hematology analyzer are: RBC (Red Blood Cell count) - the number of red cells per unit volume of blood; WBC (White Blood Cell count) - the total number of white cells, which may be further differentiated into neutrophils, lymphocytes, monocytes, eosinophils, and basophils; Hemoglobin (Hgb) - the concentration of the oxygen-carrying protein in the blood, measured in g/dL; Hematocrit (HCT) - the proportion of blood volume occupied by red cells, expressed as a percentage; Platelets (PLT) - the count of platelets, which are critical for clot formation. From these five, a series of derived red cell indices are calculated: MCV (Mean Corpuscular Volume), MCH (Mean Corpuscular Haemoglobin), MCHC (Mean Corpuscular Haemoglobin Concentration), and RDW (Red Cell Distribution Width). Accurate reporting of all five primary parameters - and, by extension, all derived indices - depends directly on the quality and correct choice of hematology reagents.

Leave a Comment

Your email address will not be published. Required fields are marked *